BPC-157: research questions and reference answers
Reference answers covering compound identity, the molecular mechanism under study, published experimental models, analytical identity and purity testing, and regulatory research status. These answers describe what published work reports and how material is characterised. They are not guidance for use in humans or animals, and nothing here is a claim that this compound is safe or effective for any purpose.
Answer style
BPC-157 is a synthetic 15-amino-acid pentadecapeptide whose sequence corresponds to a fragment reported from human gastric juice protein BPC. It is used in laboratory research as a peptide reagent in cell and tissue model systems.
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV), a 15-residue peptide with a calculated average mass near 1419.5 Da.
Published work — largely rodent and cell-culture studies from a small number of groups — examines nitric-oxide system interactions, VEGFR2 signalling, growth-factor expression and fibroblast migration in scratch/wound-closure assays. Findings are model-specific reports by their authors, not conclusions about people.
Each lot is released against a batch-specific certificate of analysis: identity by mass spectrometry (observed mass compared with the calculated monoisotopic/average mass), chromatographic purity by RP-HPLC reported as area percent at a stated wavelength, and quantity/appearance checks on the lyophilised cake. The certificate for the exact lot shipped is linked from the COA tab and the COA database.
Published human data are very limited; the literature is dominated by rodent and in-vitro studies. There is no completed, well-powered controlled trial record establishing human effects, and none of the published work has led to an approved product.
No. BPC-157 has no FDA approval for any use, has been flagged by FDA in its bulk-drug-substance review, and is supplied here solely as a laboratory research chemical for in-vitro use.
Reported systems include rodent gastrointestinal, tendon, muscle and nerve injury models, isolated vessel preparations, and cultured fibroblast and endothelial-cell assays. The PubMed tab on the product page lists current indexed publications.
Identity by mass spectrometry against the calculated 15-mer mass, purity by RP-HPLC area percent. Deletion sequences and acetylated by-products are the impurities most commonly resolved in these chromatograms.
Salt form and counter-ion affect the weight of the supplied powder and its solubility behaviour, not the peptide sequence. The certificate states the form supplied, and net peptide content should be read from it rather than assumed from vial weight.
Pure Helix supplies materials to qualified research purchasers for in-vitro laboratory use only. Nothing above is medical advice, dosing guidance, or a representation that any compound diagnoses, treats, cures, mitigates or prevents any disease. No statement here has been evaluated by the FDA.